Stockreport

EMISPHERE DEVELOPMENT UPDATE

Emmis Acquisition Corp. - Class A Ordinary Share  (EMIS) 
US:NASDAQ Investor Relations: ir.emisphere.com
PDF ROSELAND, N.J., April 06, 2020 (GLOBE NEWSWIRE) -- Novo Nordisk announced the European Commission (EC) has granted marketing authorization for Rybelsus®, (oral semaglu [Read more]